Vineeta Agarwala is a general partner at Andreessen Horowitz (a16z), where she leads investments for the firm’s bio + health fund across biotech and healthcare, with a focus on companies that are leveraging unique datasets and technologies to advance drug discovery and development, precision medicine, and innovation in patient care delivery. She was previously a consultant at McKinsey, director of product management at Flatiron Health, and venture partner at GV (Google Ventures). Vineeta completed her graduate work in computational biology and human genetics at the Broad Institute.

Vineeta holds a B.S. in biophysics from Stanford, and M.D./Ph.D. degrees from Harvard Medical School/MIT. She is board certified in internal medicine, and sees patients at Stanford as an adjunct clinical professor in the Division of Primary Care and Population Health. She works with several a16z biotech portfolio companies including Amber Bio, BigHat Bio, Gate Bio, Maze Tx, Orbital Tx, Rezo Tx, Santa Ana Bio and Ventus Tx. She also serves on the board of Tenet Healthcare and is board chair-elect at the National Venture Capital Association (NVCA).